Key result
Aortic calcification index >43 linked to ~83% higher mortality and MACE risk in PAD patients.
Why the study?
Risk for mortality, MACEs, and MALEs is considered in clinical decision-making, prompting evaluation of the association of aortic calcification with these outcomes in peripheral artery disease.
Does a high aortic calcification index predict mortality and cardiovascular events in patients with symptomatic peripheral artery disease?
Cohort (n=226)
No
Does a high aortic calcification index predict mortality and cardiovascular events in patients with symptomatic peripheral artery disease?
Hazard Ratio: 1.83 (95% CI 1.01–3.32)
p-value: p=.005
A high aortic calcification index (>43) is a strong independent predictor of all-cause mortality and major adverse cardiovascular events in patients with symptomatic peripheral artery disease undergoing invasive treatment.
OBJECTIVE: The present study evaluates the association of aortic calcification with mortality and major adverse cardiovascular and leg events (MACEs and MALEs) in patients with peripheral artery disease (PAD). The risk for mortality and MACEs and MALEs is considered in clinical decision-making. METHODS: This cohort found in 2012-2013 consists of 226 patients with symptomatic PAD referred to Turku University Hospital for invasive treatment. Follow-up data about mortality and survival without MACEs and MALEs were collected up to 5 years from the inclusion date, and aortic calcification index (ACI) was measured from patients with available imaging studies (164 of 226). ACIs' association with events and mortality was evaluated in Cox regression, Kaplan-Meier, and classification and regression tree analysis. RESULTS: All-cause mortality at 1, 3, and 5 years was 13.7% (31), 26.1% (59), and 46.9% (106), respectively. In multivariable Cox regression analysis, ACI and ACI > 43 were independent risk factors for all-cause mortality (hazard ratio [HR]: 1.13 per 10 units, 95% confidence interval [CI]: 1.00-1.22 and HR: 1.83, 95% CI: 1.01-3.32, respectively) and for MACEs (HR: 1.10 per 10 units, 95% CI: 1.00-1.22 and HR: 3.14, 95% CI: 1.67-5.91, respectively), but not for MALEs. Classification and regression tree analysis showed that ACI = 43 best divides cohort in relation to mortality. Kaplan-Meier analyses showed that ACI > 43 is associated with greater mortality and occurrence of MACEs compared with those who have ACI ≤ 43 (log-rank P value .005 and .0012, respectively). CONCLUSIONS: Risk for mortality and MACEs is associated with high ACI. ACI can expose the risk in patients with PAD for further cardiovascular events and mortality.
No takes yet. Share an insight, caveat, or question.
Rantasalo et al. (2022) conducted a cohort in Symptomatic peripheral artery disease (n=226). Aortic calcification index (ACI) > 43 vs. ACI ≤ 43 was evaluated on All-cause mortality (HR 1.83, 95% CI 1.01-3.32, p=.005). An aortic calcification index > 43 was an independent risk factor for all-cause mortality (HR 1.83; 95% CI 1.01-3.32) and major adverse cardiovascular events in patients with peripheral artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: